CRONOS GROUP INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
CRONOS GROUP INC. (CRON) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $7.60 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2022-03-01
- CRONOS GROUP INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-12-31 was $1.79M, a 16.12% decline year-over-year.
- CRONOS GROUP INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-09-30 was $1.89M, a 21.60% increase year-over-year.
- CRONOS GROUP INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-06-30 was $1.86M, a 5.31% increase year-over-year.
- CRONOS GROUP INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-03-31 was $2.06M, a 19.31% increase year-over-year.
- CRONOS GROUP INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2021 was $7.60M, a 5.83% increase from fiscal 2020.
- CRONOS GROUP INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2020 was $7.18M, a 38.16% decline from fiscal 2019.
- CRONOS GROUP INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2019 was $11.62M, a 42.55% increase from fiscal 2018.
- CRONOS GROUP INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2018 was $8.15M, a 322.11% increase from fiscal 2017.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2021-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.68M derived: sum of 2 quarters · filed 2022-03-01 | $5.54M derived: sum of 3 quarters · filed 2022-03-01 | $7.60M 10-K · filed 2022-03-01 |
| 2021-09-30 | $1.89M 10-Q · filed 2022-02-18 | $3.75M derived: sum of 2 quarters · filed 2022-02-18 | $5.81M 10-Q · filed 2022-02-18 | $7.95M derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | $1.86M 10-Q/A · filed 2022-02-18 | $3.93M 10-Q/A · filed 2022-02-18 | $6.06M derived: sum of 3 quarters · filed 2022-03-01 | $7.61M derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-03-31 | $2.06M 10-Q · filed 2021-05-07 | $4.20M derived: sum of 2 quarters · filed 2022-03-01 | $5.75M derived: sum of 3 quarters · filed 2022-03-01 | $7.52M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.69M derived: sum of 2 quarters · filed 2022-03-01 | $5.46M derived: sum of 3 quarters · filed 2022-03-01 | $7.18M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.55M 10-Q · filed 2022-02-18 | $3.32M derived: sum of 2 quarters · filed 2022-02-18 | $5.05M 10-Q · filed 2022-02-18 | $9.36M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $1.77M 10-Q/A · filed 2022-02-18 | $3.50M 10-Q/A · filed 2022-02-18 | $7.81M derived: sum of 3 quarters · filed 2022-03-01 | $10.70M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.73M 10-Q · filed 2021-05-07 | $6.04M derived: sum of 2 quarters · filed 2022-03-01 | $8.93M derived: sum of 3 quarters · filed 2022-03-01 | $11.58M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $7.20M derived: sum of 2 quarters · filed 2022-03-01 | $9.85M derived: sum of 3 quarters · filed 2022-03-01 | $11.62M 10-K · filed 2022-03-01 |
| 2019-09-30 | $2.89M 10-Q · filed 2020-11-05 | $5.54M derived: sum of 2 quarters · filed 2020-11-05 | $7.31M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $2.65M 10-Q · filed 2020-08-06 | $4.42M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $1.77M 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $8.15M 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $1.93M 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |